Fengcai Zhu
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research 69
- Viral gastroenteritis research and epidemiology 53
- Hepatology top 1%
- Hepatitis Viruses Studies and Epidemiology 24
- Health top 1%
- Vaccine Coverage and Hesitancy 28
- Modeling and Simulation top 1%
- Epidemiology top 1%
- Hepatitis B Virus Studies 40
- Influenza Virus Research Studies 27
- Respiratory viral infections research 27
-
- Viral Infections and Immunology Research 50
- Cited by
- Infectious DiseasesHepatologyHealth
- Journals
- New England Journal of Medicine (1 paper)The Lancet (3 papers)Nature Communications (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fengcai Zhu
231 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Infectious Diseases 3.6k
- Hepatology 729
- Health 673
- Modeling and Simulation 293
- Epidemiology 2.0k
Countries citing papers authored by Fengcai Zhu
This map shows the geographic impact of Fengcai Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengcai Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengcai Zhu more than expected).
Fields of papers citing papers by Fengcai Zhu
This network shows the impact of papers produced by Fengcai Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengcai Zhu. The network helps show where Fengcai Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fengcai Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trialsbreakdown → | 2023 | 68 |
| 7 | 2023 | 1 | |
| 8 | 2022 | 23 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 18 | |
| 11 | 2020 | 15 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 24 | |
| 14 | 2017 | 18 | |
| 15 | 2017 | 40 | |
| 16 | 2016 | 51 | |
| 17 | 2016 | 1 | |
| 18 | 2015 | 2 | |
| 19 | [Epidemiological characteristics of enterovirus type 71 diseases]. | 2015 | 1 |
| 20 | 2011 | 3 |
About Fengcai Zhu
Fengcai Zhu is a scholar working on Infectious Diseases, Hepatology and Health, having authored 240 papers that have together received 6.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (69 papers), Viral gastroenteritis research and epidemiology (53 papers), Viral Infections and Immunology Research (50 papers), Hepatitis B Virus Studies (40 papers), Vaccine Coverage and Hesitancy (28 papers), Influenza Virus Research Studies (27 papers), Respiratory viral infections research (27 papers) and Hepatitis Viruses Studies and Epidemiology (24 papers). The work is most often cited by research in Infectious Diseases (3.6k citations), Hepatology (729 citations) and Health (673 citations). Fengcai Zhu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jingxin Li, Lunbiao Cui, Hongxing Pan, Kai Chu, Yiyue Ge, Baoli Zhu, Bin Wu, Zhenglun Liang, Changgui Li and Yuemei Hu. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.